+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anal Fistula Epidemiology Forecast 2025-2034

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6092308
An anal fistula occurs more commonly in males. It typically develops in about 50% of individuals with an infected anal gland. Most anal fistulas, around 75%, are caused by an infected gland that forms an abscess, a pus-filled pocket that needs to drain.

Anal Fistula Epidemiology Forecast Report Coverage

The “Anal Fistula Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of anal fistula. It projects the future incidence and prevalence rates of anal fistula across various populations. The study covers age and type as major determinants of the anal fistula-affected population. The report highlights patterns in the prevalence of anal fistula over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of anal fistula in the 8 major markets.

Regions Covered

  • The United States
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Japan
  • India

Anal Fistula: Disease Overview

An anal fistula is a small tunnel that forms between the skin near the anus and the inside of the anal canal. It usually happens after an anal gland becomes infected and creates an abscess. Other common causes of an anal fistula include inflammatory bowel diseases like Crohn's disease, injury to the anal area, sexually transmitted infections (STIs) affecting the anal region, and previous surgery near the anus, among others. Maintaining a good hygiene and treating infections early can help prevent an anal fistula.

Anal Fistula: Treatment Overview

Treatment for an anal fistula usually involves surgery to close the fistula and allow it to heal properly. Fistulotomy is the most common treatment for simple fistulas. It involves cutting open the fistula to allow it to heal from the inside out. If the fistula is complex or near sensitive areas like the anal sphincter muscles, a seton (a surgical thread) may be placed through the fistula. Antibiotics may also be prescribed to treat any existing infection and prevent further complications.

Epidemiology

The anal fistula epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for anal fistula by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for anal fistula and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.
  • An anal fistula is a relatively common condition in the anorectal area and is reported to be twice as common in males than in females.
  • As per Orphanet, the prevalence of anal fistula is between 1 and 5 cases per 10,000 people.
  • The risk of developing a fistula-in-ano from an anal abscess is estimated to be between 26% and 38%.
  • Studies show that about half of the people with an infected anal gland will develop an anal fistula. Approximately 75% of anal fistulas are caused by an infected gland that forms an abscess, which is a pus-filled pocket that needs to drain.

Country-wise Anal Fistula Epidemiology

The anal fistula epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of anal fistula varies significantly between countries due to differences in healthcare access, hygiene practices, prevalence of underlying conditions (such as inflammatory bowel diseases like Crohn’s disease), and rates of anal infections or abscesses. Studies show that the overall prevalence of anal fistulas in European countries is 18.37 per 100,000 people. Italy is reported to have the highest prevalence, with 23.20 per 100,000 people.

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of anal fistula based on several factors.
  • The Anal Fistula Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population, and the unmet needs of anal fistula are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of anal fistula epidemiology in the 8 major markets?
  • What will be the total number of patients with anal fistula across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of anal fistula in the 8 major markets in the historical period?
  • Which country will have the highest number of anal fistula patients during the forecast period of 2025-2034?
  • Which key factors would influence the shift in the patient population of anal fistula during the forecast period of 2025-2034?
  • What are the currently available treatments for anal fistula?
  • What are the disease risks, signs, symptoms, and unmet needs of anal fistula?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Introduction
1.2 Objectives of the Study
1.3 Research Methodology and Assumptions
2 Executive Summary
3 Anal Fistula Market Overview - 8 MM
3.1 Anal Fistula Market Historical Value (2018-2024)
3.2 Anal Fistula Market Forecast Value (2025-2034)
4 Anal Fistula Epidemiology Overview - 8 MM
4.1 Anal Fistula Epidemiology Scenario (2018-2024)
4.2 Anal Fistula Epidemiology Forecast
5 Disease Overview
5.1 Signs and Symptoms
5.2 Causes
5.3 Risk Factors
5.4 Guidelines and Stages
5.5 Pathophysiology
5.6 Screening and Diagnosis
5.7 Types of Anal Fistula
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
7 Epidemiology Scenario and Forecast - 8 MM
7.1 Key Findings
7.2 Assumptions and Rationale
7.3 Anal Fistula Epidemiology Scenario in 8MM (2018-2034)
8 Epidemiology Scenario and Forecast: United States
8.1 Anal Fistula Epidemiology Scenario and Forecast in The United States (2018-2034)
9 Epidemiology Scenario and Forecast: United Kingdom
9.1 Anal Fistula Epidemiology Scenario and Forecast in United Kingdom (2018-2034)
10 Epidemiology Scenario and Forecast: Germany
10.1 Anal Fistula Epidemiology Scenario and Forecast in Germany (2018-2034)
11 Epidemiology Scenario and Forecast: France
11.1 Anal Fistula Epidemiology Scenario and Forecast in France
12 Epidemiology Scenario and Forecast: Italy
12.1 Anal Fistula Epidemiology Scenario and Forecast in Italy (2018-2034)
13 Epidemiology Scenario and Forecast: Spain
13.1 Anal Fistula Epidemiology Scenario and Forecast in Spain (2018-2034)
14 Epidemiology Scenario and Forecast: Japan
14.1 Anal Fistula Epidemiology Scenario and Forecast in Japan (2018-2034)
15 Epidemiology Scenario and Forecast: India
15.1 Anal Fistula Epidemiology Scenario and Forecast in India (2018-2034)
16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) Insights